NYSE · Drug Manufacturers - General

Novartis AG (NVS) Stock

$143.11 -0.12% NYSE: NVS Healthcare

Valuation

MetricValue
Price$143.11
Market Cap$272.01B
P/E Ratio21.93
P/B Ratio6.61
P/S Ratio5.01
EPS (TTM)$7.19
52-Week High$170.46
52-Week Low$121.57
Dividend Yield3.26%

Financials & Margins

MetricValue
ROE29.64%
ROA10.34%
ROCE18.07%
Gross Margin31.15%
Operating Margin31.15%
Net Margin23.09%
Debt/Equity1.18
Current Ratio1.12

Annual Financials (USD)

Metric20212022202320242025
Revenue$44.0B$43.5B$46.7B$51.7B$54.8B
Operating Profit$10.1B$7.9B$9.8B$14.5B$17.1B
Net Profit$24.0B$7.0B$14.8B$11.9B$14.1B
EPS$10.63$3.17$7.10$5.87$7.19
Op Margin22.9%18.3%20.9%28.1%31.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$131.8B$117.5B$99.9B$102.2B$115.6B
Total Liabilities$64.0B$58.0B$53.2B$58.1B$69.0B
Cash$12.4B$7.5B$13.4B$11.5B$11.4B
Borrowings$31.0B$27.9B$26.3B$31.3B$37.0B

Latest News

Chai Discovery Announces Collaboration with Novartis to Advance AI-Driven Antibody Discovery Business Wire · Jul 13, 2026 Can AI Make Better Drugs? Not on Wall Street’s Timeline The Wall Street Journal · Jul 12, 2026 Reasons Why Investors Should Consider Betting on PTC Stock Now Zacks · Jul 10, 2026 Novartis vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026? Motley Fool · Jul 9, 2026 Systemic Lupus Erythematosus Market at a Turning Point as 6 Late-Stage Emerging Therapies Set to Redefine Treatment Landscape | DelveInsight PR Newswire · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$15.1B$14.2B$14.5B$17.6B$19.2B
Investing Cash Flow$1.7B$-771.0M$2.8B$-11.3B$-6.5B
Financing Cash Flow$-3.2B$-10.5B$-5.1B$-8.5B$-9.8B
Net Cash Flow$2.7B$-4.9B$5.9B$-1.9B$-24.0M
Free Cash Flow$12.5B$12.0B$11.7B$13.8B$17.7B

Valuation & Return Ratios

MetricValue
PEG Ratio-4.88
EV / EBITDA14.35
FCF Yield5.81%
Quick Ratio0.67
Interest Coverage11.88
Return 1Y9.70%
Return 3Y60.76%
Return 5Y105.83%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABBVAbbVie Inc. $272.42 +0.39% 76.45 $481.31B 2.55%
AZNAstraZeneca PLC $158.78 -0.84% 24.77 $246.25B 1.27%
BMYBristol-Myers Squibb Company $59.58 -0.20% 13.85 $121.70B 4.01%
GILDGilead Sciences, Inc. $147.10 +0.17% -58.05 $182.40B 2.17%
GSKGSK plc $51.58 — 9.28 $103.73B 3.49%

About Novartis AG

Novartis AG is led by CEO Vasant Narasimhan, employs 75,883 people, headquartered in Basel, CH, publicly traded since 1996.

Novartis AG (NVS) stock trades at $143.11 with a market capitalization of $272.01B. The stock is valued at a price-to-earnings (P/E) ratio of 21.93, price-to-book of 6.61, price-to-sales of 5.01. Over the past 52 weeks the stock has ranged between $121.57 and $170.46, and currently trades 16.0% below its 52-week high. It pays a dividend yielding 3.26%.

On profitability, Novartis AG generates a return on equity (ROE) of 29.64% — well above the market average, a sign of a high-quality business, return on capital employed of 18.07%, an operating margin of 31.15%, a net profit margin of 23.09%.

In its most recent fiscal year, Novartis AG reported annual revenue of $54.8B, net profit of $14.1B, revenue has compounded at 1.9% a year over the last five years, profit at 11.7% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 1.18, a current ratio of 1.12, total assets of $115.6B, $11.4B in cash and equivalents.

NVS has a beta of 0.46 (less volatile than the overall market).

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21% PFE Pfizer, Inc. $27.82 -0.64%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides